Trial Profile
A PILOT STUDY TO EVALUATE THE ROLE OF 68Ga-PSMA-HBED-CC PET/CT IN PATIENTS WITH JUVENILE NASAL ANGIOFIBROMA
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Nov 2018
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Nasopharyngeal cancer
- Focus Diagnostic use
- 13 Nov 2018 New trial record